Your Source for Venture Capital and Private Equity Financings

Venture Capital News: Concerto Biosciences Raises $23M in Series A

2022-11-02
CAMBRIDGE, MA, Concerto Biosciences, a biotechnology company, announced that it raised $23 million in a Series A funding round.
Concerto Biosciences, a biotechnology company designing microbial communities that restore deficient microbiomes to treat disease, announced that it raised $23 million in a Series A funding round led by Safar Partners and joined by Horizons Ventures and M Ventures among others. Representatives from Safar Partners and M Ventures will join the company's board of directors.
(c) by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000+ startups and 5,000+ VC investors